Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

First Page		Document Content
Date: 2016-01-26 15:03:13 Gilead Sciences Chemistry HIV/AIDS Medicine Organofluorides Specialty drugs Prodrugs Prevention of HIV/AIDS AIDS Healthcare Foundation Tenofovir alafenamide Tenofovir disoproxil Fixed-dose combination		Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No Add to Reading List Source URL: www.aidshealth.org Download Document from Source Website File Size: 985,53 KB Share Document on Facebook

	67 Reduced Changes In Bone Mineral Density In CHB Patients Receiving Tenofovir Alfenamide (TAF) Compared With Tenofovir disoproxil fumarate Wai-Kay Seto2, Yasuhiro Asahina3, Cheng-Yuan Peng4, Carol Stanciu5, Djamal Abdur DocID: 1timf - View Document
	ABSTRACT FINAL ID: LB-7 TITLE: Preliminary safety and efficacy of REP 2139-Mg or REP 2165-Mg used in combination with tenofovir disoproxil fumarate and pegylated interferon alpha 2a in treatment naïve Caucasian patients DocID: 1sU8R - View Document
	PrEPARING FOR THE END OF HIV? How to access PrEP in Contra Costa County… For Insured Folks: Private Medical Provider-Most health insurance companies cover Truvada (emtricitabine and tenofovir disoproxil fumarate, the m DocID: 1rAVd - View Document
	Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No DocID: 1rqYi - View Document
	March 4, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By: DocID: 1rdax - View Document